CEACAM5 and neoplasm: According to the serum cfDNA level of pre/postchemotherapy CRC cohort and tumor biomarker (CEA, CA125, and VEGF) expression profiles, the specificity/sensitivity of these indexes for CRC diagnostic purposes was determined, followed by drawing of corresponding ROC curves (Figure 2).